Prosecution Insights
Prosecution Insights
5 pending office actions • 0 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §102 only | 1 (20%) |
| §112 only | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHMIDT, IZABELA MARIA | 1 | 64.5% | +44.7% |
| BAUER, NICOLA MARIA | 1 | 57.7% | +46.2% |
| HIRAKIS, SOPHIA P | 1 | 52.2% | +73.3% |
| MAHLUM, JONATHAN DAVIS | 1 | 53.3% | +19.0% |
| CORNET, JEAN P | 1 | 42.0% | +47.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19034034 | Synthetic Cannabigerol Quinone Analogs and Pharmaceutical Compositions Containing Same for Treating Neurological Disorders | SCHMIDT, IZABELA MARIA | — |
| 18891657 | ANTI-inflammatory Compounds, pharmaceutical compositions, and methods of treating disorders associated with inflammation | BAUER, NICOLA MARIA | — |
| 18891628 | Pharmaceutical Compounds, Pharmaceutical compositions, and methods of treating hair loss and other disorders | HIRAKIS, SOPHIA P | — |
| 18891706 | ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS | MAHLUM, JONATHAN DAVIS | — |
| 18721001 | Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods | CORNET, JEAN P | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19034034 | Synthetic Cannabigerol Quinone Analogs and Pharmaceutical Compositions Containing Same for Treating Neurological Disorders | SCHMIDT, IZABELA MARIA | — | §103 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 18891657 | ANTI-inflammatory Compounds, pharmaceutical compositions, and methods of treating disorders associated with inflammation | BAUER, NICOLA MARIA | — | §102 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18891628 | Pharmaceutical Compounds, Pharmaceutical compositions, and methods of treating hair loss and other disorders | HIRAKIS, SOPHIA P | — | §112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18891706 | ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS | MAHLUM, JONATHAN DAVIS | — | §112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18721001 | Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods | CORNET, JEAN P | — | §112 | Non-Final OA | — | Pending | Jun 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial